Sensipar

Under copycat attack, Amgen punches back with its own biosimilars
Fierce Pharma
Tue, 10/29/19 - 10:48 pm
Amgen
biosimilars
generics
Sensipar
Neulasta
Neupogen
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Tue, 03/13/18 - 09:30 pm
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
FDA
generics
Amgen
Sensipar
Cipla
Aurobindo
Amgen Challenge of FDA Decision on Pediatric Exclusivity Could Have Wider Implications
RAPS.org
Wed, 11/8/17 - 06:26 pm
Amgen
FDA
pediatric exclusivity
Sensipar
Amgen Sues FDA After Agency Denies Pediatric Exclusivity for SENSIPAR
FDA Law Blog
Wed, 05/31/17 - 09:28 am
Amgen
FDA
pediatric exclusivity
Sensipar
patents
chronic kidney disease
Top 25 rare disease brands, by sales
Medical Marketing and Media
Wed, 02/15/17 - 11:20 am
rare disease
Copaxone
Teva Pharmaceutical
Avonex
Biogen
Sensipar
Soliris
Alexion
Xyrem
Jazz Pharmaceuticals
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Fierce Biotech
Thu, 02/26/15 - 10:26 am
Amgen
AMG416
Sensipar
secondary hyperparathyroidism
FDA halts pediatric study of Amgen's Sensipar after death
Fierce Pharma
Fri, 03/1/13 - 12:00 pm
Sensipar
Amgen
FDA
clinical trials
hyperparathyroidism
Amgen's Sensipar fails in late-stage trial
Pharma Times, UK
Mon, 06/11/12 - 01:04 pm
Amgen
Sensipar
kidney disease
Amgen Wins Ruling Blocking Teva’s Generic Sensipar
Bloomberg
Sat, 01/8/11 - 11:52 am
Amgen
Teva Pharmaceuticals
Sensipar
FDA grants tentative approval for Teva's Cinacalcet HCl Tablets ANDA
News-Medical
Sat, 05/15/10 - 01:05 pm
Teva Pharmaceuticals
FDA
Cinacalcet HCl
Sensipar
secondary hyperparathyroidism